Lymphocyte-to-C-reactive protein ratio predicts prognosis in unresectable locally advanced non-small cell lung cancer patients
LCR is a promising prognostic index in patients with LA-NSCLC undergoing chemoradiotherapy, and an increase in the LCR level contributes to better outcomes.
Authors
- Zhengcao Liu
- Shengjun Ji (ORCID: https://orcid.org/0000-0002-8862-6256)
- Jinping Li (ORCID: https://orcid.org/0000-0003-4891-922X)
- Qingqing Chen (ORCID: https://orcid.org/0009-0008-6420-3145)
- Xiang Ji (ORCID: https://orcid.org/0000-0003-2856-4070)
- Yingying Xu
Institutions
- Soochow University (CN)
- Linzi District People's Hospital (CN)
- Second Affiliated Hospital of Soochow University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1080/07853890.2025.2487629
- Citations
- 4
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 4.18